Table 5.
Results of outcome measures assessed in the observational cohort study
| Outcome measure | Baseline | Completion | Change | P |
|---|---|---|---|---|
| ISWT (m) | 80.0 (30.0 to 212.5) | 365.0 (250.0 to 477.5) | 265.0 (207.5 to 300.0) | .0002 |
| 6MWT (m) | 167.0 (60.0 to 293.5) | 433.5 (318.3 to 481.0) | 157.5 (131.3 to 321.3) | .0002 |
| SF-36 v2 PCS (/100) | 34.0 (28.2 to 41.4) | 42.7 (35.7 to 48.5) | 6.4 (1.7 to 13.1) | .01 |
| SF-36 v2 MCS (/100) | 44.4 (34.9 to 52.6) | 51.4 (43.1 to 57.2) | 4.7 (− 1.8 to 11.4) | .03 |
| HADS | ||||
| Total (/42) | 10.0 (6.8 to 14.0) | 9.0 (6.5 to 13.0) | 0.5 (− 3.3 to 4.5) | .8 |
| Anxiety (/21) | 5.0 (3.0 to 7.5) | 4.0 (2.8 to 8.3) | 0.0 (− 2.0 to 3.3) | .7 |
| Depression (/21) | 5.5 (2.8 to 7.3) | 5.5 (1.8 to 7.5) | 1.0 (− 2.5 to 3.3) | .8 |
Data are presented as median (IQR) (n = 14). P values derived from Wilcoxon signed rank test and reflect change from baseline to completion.